Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes
Open Access
- 11 April 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (10) , 1833-1844
Abstract
Increased expression of the homodimeric S100A8 (A8) and S100A9 (A9) alarmins and their Calprotectin (CP) antimicrobial hetero-complex has been reported in Inflammatory Skin Diseases (ISDs) such as Atopic Dermatitis (AD), but the functional consequences of this increase are not known. We evaluated the cell- and tissue-specific functions of A8 and A9 in the local and the extra-cutaneous manifestations of ISD using genetically engineered mouse models. The genes encoding for the A9 or A8 proteins were inactivated in epidermal cells or neutrophils in the JunB ∆ep genetic mouse model for AD. Overall, epidermal inactivation of A9 aggravated, while similar A8 inactivation ameliorated experimental ISD. Epidermal differentiation and skin inflammation was also ameliorated when A9 was inactivated in neutrophils or in all cells. However, complete A9 knock-out was associated with worsened systemic effects, such as neutrophilic inflammation and bone loss. In addition, the distal phalanges of the digits displayed increased A8 protein expression, SA overgrowth and bone destruction. Epidermal A8 inactivation ameliorated bone loss, but promoted bone destruction in the digits, likely through A8-positive neutrophilic infiltrates. These data show that site- and cell-type-specific A8 and A9 expression modulates chronic skin and systemic inflammation with distinct effects on the skin differentiation and on the musculoskeletal system. These findings pave the way for novel therapies targeting the divergent functions of A8 and A9 to restore epidermal homeostasis and prevent systemic complications.Keywords
This publication has 57 references indexed in Scilit:
- The genetics of asthma and allergic disease: a 21st century perspectiveImmunological Reviews, 2011
- Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signalingProceedings of the National Academy of Sciences, 2009
- Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formationNature Cell Biology, 2008
- Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin diseaseArthritis Research & Therapy, 2007
- Skin colonization byStaphylococcus aureusin patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trialBritish Journal of Dermatology, 2006
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem CellsCell, 2004
- S100A8: emerging functions and regulationJournal of Leukocyte Biology, 1999
- Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectinThe Lancet, 1990
- Osteomyelitis of the distal phalanges in three children with severe atopic dermatitisArchives of Dermatology, 1988